Pharmaceutical supply chains are about to face their biggest security challenge for a generation as the world prepares for life-changing deliveries of Covid vaccines, says the Transported Asset Protection Association (TAPA).
An estimated 7-19 billion doses of the vaccine will be required to eradicate Covid-19 globally, enabling 60-70% of the global population to gain immunity and to stop the virus from spreading. With over 50 million confirmed cases of the virus still being treated and the tragic loss of more than 1.2m lives, the world is waiting for a vaccine to deliver long-awaited health and wellbeing assurances.
